IL-23p19 Antagonists vs. Ustekinumab for Treatment of Crohn’s Disease: A Meta-analysis of Randomized Controlled Trials
Related Posts
Danpanichkul P, Pang Y, Díaz LA, White TM, Sirimangklanurak S, Auttapracha T, Suparan K, Syn N, Jatupornpakdee P, Saowapa S, Ng CH, Kaewdech A, Lui[...]
Hanauer SB, Torres EA, Aragon-Han P, Chapman JC, Swaminath AC, Arai R, Butnariu M, Lee TC, Rabizadeh S, Check M, Barrett TA, Hashash JG, Meister[...]
Scarlata K, Zickgraf HF, Satherley RM, Shapiro JM, Adams DW, Smith J, Collins S, Taft T. A Call to Action: Unraveling the Nuance of Adapted[...]